Role of AcrAB-TolC multidrug efflux pump in drug-resistance acquisition by plasmid transfer.
Sophie NolivosJulien CayronAnnick DedieuAdeline PageFrédéric DelolmeChristian LesterlinPublished in: Science (New York, N.Y.) (2019)
Drug-resistance dissemination by horizontal gene transfer remains poorly understood at the cellular scale. Using live-cell microscopy, we reveal the dynamics of resistance acquisition by transfer of the Escherichia coli fertility factor-conjugation plasmid encoding the tetracycline-efflux pump TetA. The entry of the single-stranded DNA plasmid into the recipient cell is rapidly followed by complementary-strand synthesis, plasmid-gene expression, and production of TetA. In the presence of translation-inhibiting antibiotics, resistance acquisition depends on the AcrAB-TolC multidrug efflux pump, because it reduces tetracycline concentrations in the cell. Protein synthesis can thus persist and TetA expression can be initiated immediately after plasmid acquisition. AcrAB-TolC efflux activity can also preserve resistance acquisition by plasmid transfer in the presence of antibiotics with other modes of action.
Keyphrases
- escherichia coli
- crispr cas
- gene expression
- single cell
- klebsiella pneumoniae
- genome wide
- biofilm formation
- single molecule
- cell therapy
- dna methylation
- drug resistant
- high resolution
- poor prognosis
- stem cells
- signaling pathway
- high throughput
- binding protein
- young adults
- mass spectrometry
- cystic fibrosis
- pseudomonas aeruginosa
- multidrug resistant
- circulating tumor
- transcription factor
- label free